| 100019-9 | ALK gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100020-7 | GNA11 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100021-5 | GNAQ gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100022-3 | IDH1 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100023-1 | IDH2 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100024-9 | SETBP1 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100025-6 | SRSF2 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100026-4 | MET gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100027-2 | SMAD4 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100028-0 | FBXW7 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100034-8 | Provider of automated external defibrillator use |
| 100035-5 | Exam finding location of Chest |
| 100036-3 | Exam finding location of Lung |
| 100037-1 | Patient contact disposition EMS unit |
| 100038-9 | Patient evaluation disposition EMS unit |
| 100039-7 | Crew disposition for patient care EMS unit |
| 100040-5 | Patient transport disposition EMS unit |
| 100063-7 | Primary skin concern |
| 100068-6 | Right eye Fixation point |
| 100069-4 | Left eye Fixation point |
| 100086-8 | Right cornea Type of Analysis method (specular microscopy) |
| 100154-4 | Specimen collection supervision level |
| 100155-1 | Left cornea Type of Analysis method (specular microscopy) |
| 100156-9 | SARS-CoV-2 (COVID-19) variant in Specimen (naa with probe detection) |
| 100157-7 | SARS-CoV-2 (COVID-19) lineage in Specimen (sequencing) |
| 100180-9 | Assistive mobility devices used |
| 100289-8 | Absence of hip deformity measurements |
| 100317-7 | Relationship of usual support person for daily activities |
| 100319-3 | Relationship of financial support person |
| 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA in Specimen (naa with probe detection) |
| 100370-6 | Orthopoxvirus DNA in Specimen (naa with probe detection) |
| 1006-6 | Direct antiglobulin test.IgG specific reagent on Red Blood Cells |
| 100670-9 | RHD gene allele cell-free DNA Nominal--fetus |
| 100696-4 | CTNS related multigene analysis in Bodyfluid and Serum or Plasma (molecular genetics method nominal) |
| 100752-5 | Exacerbating factors - Reported |
| 100753-3 | Alleviating factors - Reported |
| 100756-6 | Oligoclonal bands (CSF, isoelectric focusing) |
| 100823-4 | Initial portable medical treatment orders |
| 100825-9 | Medically assisted nutrition orders |
| 100826-7 | Portable medical order AndOr advance directive review |
| 100827-5 | Portable medical order discussion participants |
| 100864-8 | Giardia lamblia bg gene in Specimen (molecular genetics method) |
| 100868-9 | Cryptosporidium sp 18S-LC2 rRNA in Specimen (molecular genetics method) |
| 100869-7 | Cryptosporidium gp60 gene in Specimen (molecular genetics method) |
| 100870-5 | Cryptosporidium 18S rRNA in Specimen (molecular genetics method) |
| 100871-3 | Giardia lamblia gdh gene in Specimen (molecular genetics method) |
| 100873-9 | Giardia lamblia tpi gene in Specimen (molecular genetics method) |
| 100895-2 | Rickettsia conorii IgG and IgM |
| 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype in Specimen (organism specific culture) |
| 100901-8 | Enterobacteriaceae.carbapenemase resistance phenotype in Anal (organism specific culture) |
| 100902-6 | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 in Anal (organism specific culture) |
| 100905-9 | Gram positive bacteria identified in Isolate (organism specific culture) |
| 100907-5 | Vancomycin resistant enterococcus in Specimen (organism specific culture) |
| 100910-9 | Gram negative bacteria.colistin resistant identified (Stool, organism specific culture) |
| 100965-3 | Dengue virus IgG Ab, Plasma or Blood |
| 100975-2 | Induced abortion method |
| 100983-6 | HIV reverse transcriptase failed codons (genotype method) |
| 100984-4 | HIV 1 group M RNA genotype (genotype method) |
| 100985-1 | HIV protease failed codons (genotype method) |
| 100986-9 | HIV integrase failed codons (genotype method) |
| 101003-2 | Monkeypox virus clade in Specimen (sequencing) |
| 101004-0 | Monkeypox virus lineage in Specimen (sequencing) |
| 101114-7 | NCSBN ID |
| 101142-8 | NAT2 gene allele or Tissue (Blood, molecular genetics method nominal) |
| 101193-1 | Sphincter excision plane in Colorectal cancer specimen |
| 101194-9 | Mesocolic excision plane in Colorectal cancer specimen |
| 101196-4 | Inflammatory cell infiltrate in Colorectal cancer specimen |
| 101327-5 | MDS v3.0 - RAI v1.18.11 - Nutritional approaches - on admission during assessment period |
| 101328-3 | MDS v3.0 - RAI v1.18.11 - Nutritional approaches - at discharge during assessment period |
| 101331-7 | MDS v3.0 - RAI v1.18.11 - Ulcers, wounds and skin problems during assessment period |
| 101332-5 | MDS v3.0 - RAI v1.18.11 - Reason referral to local contact agency not made |
| 101333-3 | MDS v3.0 - RAI v1.18.11 - Determination of pressure injury risk |
| 101349-9 | Jurisdiction where advance directive is accepted |
| 101351-5 | Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living during assessment period |
| 101356-4 | Borrelia afzelii+burgdorferi+garinii Ab (ia.mttt) |
| 101358-0 | Borrelia burgdorferi Ab (ia.mttt) |
| 101394-5 | Sex in Embryo (molecular genetics method) |
| 101399-4 | Monkeypox virus and Orthopoxvirus.non-variola DNA in Specimen (naa with probe detection) |
| 101516-3 | Salmonella dublin Ab/Negative control in Specimen (immunoassay) |
| 101522-1 | Porcine deltacoronavirus S gene in Isolate (sequencing) |
| 101527-0 | Porcine epidemic diarrhea virus S1 gene in Isolate (sequencing) |
| 101528-8 | Mycoplasma sp DNA in Isolate (sequencing) |
| 101529-6 | Mycoplasma sp DNA in Isolate (sequencing) |
| 101534-6 | Fungal 18s rRNA gene in Specimen (sequencing) |
| 101535-3 | Fungal 18s rRNA gene in Specimen (sequencing) |
| 101536-1 | Salmonella sp whole genome in Isolate (sequencing) |
| 101537-9 | AGA gene |
| 101539-5 | Tyrosine |
| 101545-2 | FCGR3A gene.p.Phe158 (Blood, molecular genetics method nominal) |
| 101546-0 | FCGR3A gene.p.Val158 (Blood, molecular genetics method nominal) |
| 101576-7 | Bacterial gyrB gene drug resistance mutation (molecular method) |
| 101590-8 | VKORC1 gene allele or Tissue (Blood, molecular genetics method nominal) |
| 101605-4 | CMS - Nutritional approaches - at discharge during assessment period |
| 101608-8 | CMS - Determination of Pressure Ulcer during assessment period |
| 101610-4 | CMS - Other Ulcers, Wounds and Skin Problems during assessment period |
| 101616-1 | CMS - Participation in assessment and goal setting during assessment period |
| 101621-1 | CMS - Reason referral to local contact agency not made during assessment period |
| 10163-4 | History of pregnancies |
| 101632-8 | CMS - Nutritional approaches - on admission during assessment period |
| 101658-3 | Cancer staging after multimodality therapy |